ASHLEY BAKSH: Open Payments
NPI 1598273328 · GILROY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,111 in 193 payments from 20 companies in 2025. Trend: 2023 $3,323 · 2024 $3,963 · 2025 $4,111
Food & beverage: $3,900Education: $211
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 19 | $491 |
| ABBVIE INC. | 22 | $390 |
| GENZYME CORPORATION | 10 | $390 |
| UCB, Inc. | 18 | $385 |
| Incyte Corporation | 17 | $351 |
| Novartis Pharmaceuticals Corporation | 18 | $307 |
| Arcutis Biotherapeutics, Inc. | 15 | $299 |
| Galderma Laboratories, L.P. | 14 | $293 |
| Janssen Biotech, Inc. | 17 | $287 |
| PFIZER INC. | 16 | $280 |
Products named: DUPIXENT, Bimzelx, OPZELURA, Zoryve, NEMLUVIO, TREMFYA, CIBINQO, SKYRIZI.
Industry payments across CA — which companies pay providers there.
